SERPINI1 – Progressive Myoclonus Epilepsy

Progressive myoclonus epilepsy (PME) is a rare neurodegenerative disorder characterized by action myoclonus, tonic–clonic seizures, ataxia and cognitive decline. SERPINI1 encodes neuroserpin, a serine protease inhibitor predominantly expressed in neurons, with pathogenic variants known to cause neuroserpin polymerisation and neuronal inclusion bodies. Genetic and functional data support a role for SERPINI1 in PME.

A familial case report described a heterozygous SERPINI1 missense variant c.154A>C (p.Ser52Arg) segregating with PME in two siblings and their affected mother; all three had myoclonus, epilepsy and developed dementia by mid-adulthood (PMID:11138927). Neuropathology revealed periodic acid–Schiff–positive eosinophilic bodies in cortex and subcortical neurons consistent with mutant neuroserpin accumulation.

In a large exome sequencing study of 84 unrelated PME cases, a second heterozygous SERPINI1 variant c.1175G>A (p.Gly392Glu) was identified in a sporadic individual, contributing to case-level evidence for SERPINI1 in PME (PMID:25401298). Overall, there are four probands across two families with two distinct missense variants demonstrating autosomal dominant inheritance and segregation (two additional affected relatives).

Functional studies demonstrate that mutant neuroserpin accumulates as polymers in the endoplasmic reticulum (ER) of neurons, triggering ER stress and inclusion body formation. ER-associated degradation (ERAD) pathways involving OS-9, Hrd1 and gp78 mediate clearance of mutant neuroserpin, and impairment of ERAD exacerbates polymer load (PMID:24795221; PMID:21507957). N-linked glycosylation at Asn157 and Asn321 modulates polymerisation and degradation of neuroserpin variants (PMID:26367528).

No conflicting reports have been published disputing SERPINI1 association with PME. The convergence of familial segregation, multiple independent variants and concordant functional pathology supports a clinically meaningful association.

Key Take-home: SERPINI1 pathogenic missense variants cause autosomal dominant PME via neuroserpin polymer accumulation; genetic testing including SERPINI1 should be considered in PME diagnostic panels.

References

• Journal of neuropathology and experimental neurology • 2000 • Neuroserpin mutation S52R causes neuroserpin accumulation in neurons and is associated with progressive myoclonus epilepsy PMID:11138927
• Nature genetics • 2015 • A recurrent de novo mutation in KCNC1 causes progressive myoclonus epilepsy PMID:25401298
• Neurobiology of aging • 2014 • Lectin OS-9 delivers mutant neuroserpin to endoplasmic reticulum associated degradation in familial encephalopathy with neuroserpin inclusion bodies PMID:24795221
• The Journal of biological chemistry • 2011 • The endoplasmic reticulum (ER)-associated degradation system regulates aggregation and degradation of mutant neuroserpin PMID:21507957
• The FEBS journal • 2015 • Interactions between N-linked glycosylation and polymerisation of neuroserpin within the endoplasmic reticulum PMID:26367528

Evidence Based Scoring (AI generated)